You are here

Identification of new therapeutic targets to control invasive behaviours of brain cancers

Description 
Brain cancers are notoriously aggressive, and current treatments are often ineffective at preventing disease progression. This research project focuses on identifying new therapeutic targets to control the invasive behaviours of brain cancers. Using various experimental approaches, we investigate the mechanisms behind the progression of brain cancers and aim to identify novel therapeutic targets that could potentially prevent or slow the spread of the disease. By elucidating the signalling pathways involved in cancer invasion, we hope to develop more effective treatments that can improve the outcomes of patients with brain cancer. Our recent research has been on medulloblastoma, the most common malignant childhood brain tumour. This project uses wide range of experimental approach including in vitro and in vivo models, cell imaging, cell-based assays, RNA and protein analyses, drug screening, omics studies, and patient data analysis.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
Cancer, Brain cancer, Cell signalling, Drug discovery, Metastasis
School 
Biomedicine Discovery Institute (School of Biomedical Sciences) » Pharmacology
Available options 
PhD/Doctorate
Masters by research
Masters by coursework
Honours
BMedSc(Hons)
Short projects
Joint PhD/Exchange Program
Medical Education
Time commitment 
Full-time
Part-time
Top-up scholarship funding available 
No
Physical location 
Clayton Campus
Co-supervisors 
Dr 
Iman Azimi

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.